GB Pharma Holdings in collaboration with its partner AHAR Pharma, initiate 90-Day bridging trial for the efficacy of Low Dose Naltrexone [LDN], marketed as Lodonal™, in HIV/AIDS patients....
We are excited to inform you that, this year, during the second edition of the GB Group Global Leadership Awards we will focus on women leaders in Africa. We will be honoring women that currently influence government policy through political participation, economic development through entrepreneurialism...
